ABBV Acquires APGE
AbbVie is acquiring Apogee Therapeutics to deepen its immunology portfolio
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
AbbVie is acquiring Apogee Therapeutics to deepen its immunology portfolio
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.